Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study).
Saved in:
| Title: | Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study). |
|---|---|
| Authors: | Leszek P; Heart Failure Transplantology and Mechanical Circulatory Support Department, National Institute of Cardiology, Alpejska 42, 04-628 Warsaw, Poland., Csanádi Z; Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Gruev I; Cardiology Department, National Multiprofile Transport Hospital 'Tsar Boris III' Sofia, Sofia, Bulgaria., Uuetoa T; Cardiology Center, Confido Medical Centre, Tallinn, Estonia., Žaliaduonytė D; Heart Center, Lithuanian University of Health Sciences, Medical Academy, Kaunas, Lithuania.; Heart Center, Kaunas Hospital of Lithuanian University of Health Science, Kaunas, Lithuania., Miličić D; Department of Cardiovascular Diseases, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia., Trušinskis K; Latvian Center of Cardiology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia., Baukienė J; Medical Affairs, AstraZeneca, Vilnius, Lithuania., Isvoranu AM; Medical Affairs, AstraZeneca, Bucharest, Romania., Chioncel O; Department Cardiology 1, 'C.C. Iliescu' Institute of Cardiovascular Diseases, Bucharest, Romania. |
| Source: | ESC heart failure [ESC Heart Fail] 2026 May 05; Vol. 13 (3). |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model: Print Cited Medium: Internet ISSN: 2055-5822 (Electronic) Linking ISSN: 20555822 NLM ISO Abbreviation: ESC Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
